SHOT IN THE ARM. As drug companies scramble to develop a vaccine for Covid-19, they’re getting a booster shot from other inoculations. Demand for winter flu jabs on Thursday allowed French drugmaker Sanofi to boost its 2020 earnings guidance. Vaccine sales were up nearly 14% to more than 2 billion euros in the three months to September. British peer GSK reported a similar surge on Wednesday; sales of its flu vaccine business grew 21% in the third quarter.
HOLDING PATTERN. Royal Dutch Shell has given bruised shareholders another dividend surprise, but this time one they’ll like. After a two-thirds cut in April, boss Ben van Beurden served up a 4% increase to the company’s third-quarter payout. He also pledged to pay shareholders 20%-30% of operating cash flow once he cuts net debt to $65 billion.
HOOKED ON CHINA. Yet another multinational is chalking up a robust third quarter to the Chinese Communist Party’s handling of the Covid-19 crisis. Volkswagen returned to profitability in the three months ended Sept. 30, saying that “a key driver of this development was China, the Group’s largest single market”. While deliveries in the People’s Republic are down 10% to 2.7 million vehicles in the first nine months of the year compared to 2019, they popped 3% in the third quarter.
Breakingviews thanks for this news
Breakingviews Selllllllll!!!!!
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Breakingviews - Corona Capital: Snus, Construction M&A, CapgeminiFrom Breakingviews: Capgemini’s third-quarter results reveal some virus immunity, and a plasterboard sale exposes Boral’s past mistakes. Catch up with the latest financial insights Breakingviews wow
Source: Reuters - 🏆 2. / 97 Read more »
Source: Reuters - 🏆 2. / 97 Read more »
Source: Reuters - 🏆 2. / 97 Read more »
Source: Breakingviews - 🏆 470. / 51 Read more »
Source: HuffPostParents - 🏆 414. / 53 Read more »